This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: The General Hospital Corporation, Visterra, Inc.. Active years: 2024.
Company Filing History:
1 out of 3,071 
1 out of 38 
Years Active: 2024
Title: The Innovations of Thiago de Jesus Borges
Introduction
Thiago de Jesus Borges is an accomplished inventor based in Charlestown, MA, known for his contributions in the biomedical field. With a notable patent to his name, Borges has made significant strides in the area of interleukin-2 agents, showcasing his innovative approach to treating various disorders.
Latest Patents
Borges holds a patent titled "Methods of using interleukin-2 agents," which discloses IL-2 variants and outlines methods, compositions, and their uses. These IL-2 agents can be utilized for the treatment and prevention of multiple disorders and conditions, emphasizing their potential therapeutic applications in the medical field.
Career Highlights
Throughout his career, Thiago de Jesus Borges has been associated with renowned organizations such as Visterra, Inc., and The General Hospital Corporation. His role in these companies has allowed him to further develop his pioneering work in the realm of immunotherapy and innovative treatment methods.
Collaborations
Borges has worked alongside talented professionals in his field, including Scott Moore Carlson and Gregory Babcock. These collaborations have not only enhanced his research but have also contributed to the overall advancements in therapeutic techniques related to IL-2 agents.
Conclusion
Thiago de Jesus Borges stands out as a prominent figure in innovation, particularly in the area of medical treatments involving interleukin-2 agents. With his patent and collaborative efforts, he continues to influence the prospects of biomedical research and therapeutic development.